16. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
Gesellschaft für Arzneimittelforschung und Arzneimittelepidemiologie
19.11. - 20.11.2009, Berlin
Poster
Meeting Abstract
(09gaa14)
[Volltext]
Reporting of safety issues in clinical trials, SUSAR and DSUR
Siegert J, Kosa M, Brecht B, Böhme A, Schröder J, Schindler C, Kirch W[Volltext]
Meeting Abstract
(09gaa15)
[Volltext]
Preventability of adverse drug reactions leading to hospital admission – assessment of inter-rater variability within the Network of Regional Pharmacovigilance Centers
Schmiedl S, Szymanski J, Rottenkolber M, Drewelow B, May K, Hippius M, Farker K, Hasford J, Thürmann PA[Volltext]
Meeting Abstract
(09gaa16)
[Volltext]
Development and application of an electronic tool for the collection of medication data in pharmacoepidemiological studies
Quinzler R, Zint K, Raum E, Brenner H, Metzner M, Haefeli WE[Volltext]
Meeting Abstract
(09gaa17)
[Volltext]
Medication review of patients community-dwelling seniors using high-level homecare service
Ermer M, Harder S[Volltext]
Meeting Abstract
(09gaa18)
[Volltext]
How are asthma types coded in the out-patient sector? Analysis of claims data from 2004–2007
Windt R, Glaeske G[Volltext]
Meeting Abstract
(09gaa19)
[Volltext]
Is there a correlation between hormone therapy and the prescription of antidepressants?
Gerdau-Heitmann C, Glaeske G, Janhsen K[Volltext]
Meeting Abstract
(09gaa20)
[Volltext]
Prescription patterns of drugs inhibiting the renin-angiotensin-aldosterone-system (RAAS) in the Federal State of Saxony – an analysis of the AOK health insurance service database in the years 2003 and 2004
Kosa M, Siegert J, Brecht B, Schröder J, Maywald U, Kirch W, Schindler C[Volltext]
Meeting Abstract
(09gaa21)
[Volltext]
Prescription of antidepressants and comorbidity of depression
Schicktanz C, Glaeske G, Janhsen K[Volltext]
Meeting Abstract
(09gaa22)
[Volltext]
Private prescriptions of zolpidem and zopiclone: What medication claims data won't tell us
Hoffmann F, Glaeske G[Volltext]
Meeting Abstract
(09gaa23)
[Volltext]
Insulin glargin stellt eine kostengünstige Alternative im Vergleich zu NPH-Insulin bei der Behandlung insulinpflichtiger Diabetiker dar: Ergebnisse einer Verordnungsdatenanalyse
Dippel FW, Schneider T, Schöffski O, Ponzel R, Kleinfeld A[Volltext]
Meeting Abstract
(09gaa24)
[Volltext]
Resource utilization and treatment costs in type 2 diabetes on intensified insulin therapy with insulin glargine compared to insulin detemir under real world conditions in Germany
Bierwirth RA, Knollmeyer J, Kohlmann T, Holle R[Volltext]
Meeting Abstract
(09gaa25)
[Volltext]
Consumption of intranasal corticosteroid-containing sprays (INS) for the treatment of allergic rhinitis – a comparison of "real life" prescription data of treatment with budesonide and mometasone in Germany
Schöffski O, Becker B[Volltext]
Meeting Abstract
(09gaa26)
[Volltext]
ATC-based determination of the specialization of Statutory Health Insurance Accredited Physicians
Schuster R.[Volltext]
Meeting Abstract
(09gaa27)
[Volltext]
Patient information needs identified by a drug information service
Goltz L, Kosa M, Lochner S, Schröder J, Siegert J, Schindler C, Kirch W[Volltext]
